Drug Costs for COVID-19 Patients in U.S. Hospitals Drop But May Rise Again

Medication costs for COVID-19 patients hospitalized in the United States have dropped sharply since May, reflecting advances in treatment, shorter stays and use of cheaper generic drugs. But costs may rise again as hospitals start to pay for Gilead Sciences …

from News – Insurance Journal